Get Premium to unlock powerful stock data
Affimed NV logo

Affimed NV

$ 3.27 +0.2 (+6.51%) 10:08 PM EST
P/E:
At Loss
P/B:
2.63
Market Cap:
$ 488.27M
Enterprise V:
$ 302.56M
Volume:
1.86M
Avg Vol (2M):
2.27M
Also Trade In:
Volume:
1.86M
Market Cap $:
488.27M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.27M
Enterprise Value $:
302.56M
PB Ratio:
2.63
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Affimed NV
NAICS : 325414 SIC : 2836
Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120
Description
Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.
Name Current Vs Industry Vs History
Cash-To-Debt 10.57
Equity-to-Asset 0.6
Debt-to-Equity 0.14
Debt-to-EBITDA -0.33
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.92
Distress
Grey
Safe
Beneish M-Score -1.59
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 45.27
9-Day RSI 40.08
14-Day RSI 39.37
6-1 Month Momentum % -26.4
12-1 Month Momentum % -50.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.2
Quick Ratio 3.19
Cash Ratio 3.06
Days Sales Outstanding 34.35

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.5

Financials (Next Earnings Date:2022-07-01 Est.)

AFMD's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:AFMD

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 47.447
EPS (TTM) ($) -0.561
Beta 2.37
Volatility % 59.68
14-Day RSI 39.37
14-Day ATR ($) 0.279991
20-Day SMA ($) 3.696
12-1 Month Momentum % -50.9
52-Week Range ($) 2.88 - 9.82
Shares Outstanding (Mil) 149.32

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Affimed NV Filings

Document Form Filing Date
No Filing Data

Headlines

See More